 HAMILTON , Ontario and BOSTON, Nov. 11, 2021 PRNewswire -- Fusion Pharmaceuticals Inc. Nasdaq: FUSN, a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that the Company will present at the 2021 Jefferies London Healthcare Conference. A recording of the presentation will be made available for on-demand viewing on Thursday, November 18, 2021 at 8:00am GMT. 